Showing results (161-170 of 193) with videos related to

Sort By:
Pageof 20
JAMA|May 2, 2013
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trialSimon R M Dobson, Shelly McNeil, Marc Dionne, et al.
The New England Journal of Medicine|May 15, 2007
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesSuzanne M Garland, Mauricio Hernandez-Avila, Cosette M Wheeler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2019
Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical TrialRobine Donken, Simon R M Dobson, Kim D Marty, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 29, 2025
FIGO guideline on liver disease and pregnancyMelanie Nana, Virna Medina, Cynthia Maxwell, et al.
JAMA|December 15, 2025
The Role of Vaccination in Maternal and Perinatal Outcomes Associated With COVID-19 in PregnancyElisabeth McClymont, Sandra Blitz, Lucia Forward, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 17, 2018
A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune ResponseScott A Halperin, Joanne M Langley, Lingyun Ye, et al.
JMIR Research Protocols|June 16, 2022
Ensuring a Successful Transition From Cytology to Human Papillomavirus-Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women's Intentions: Protocol for an Observational StudyGabrielle Griffin-Mathieu, Ben Haward, Ovidiu Tatar, et al.
Lancet (London, England)|May 22, 2007
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trialsElmar A Joura, Sepp Leodolter, Mauricio Hernandez-Avila, et al.
Women'S Health (London, England)|April 18, 2022
Key recommendations for developing a national action plan to advance the sexual and reproductive health and rights of women living with HIV in CanadaAngela Kaida, Brittany Cameron, Tracey Conway, et al.
Papillomavirus Research (Amsterdam, Netherlands)|October 28, 2017
Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by regionXavier Castellsagué, Kevin A Ault, F Xavier Bosch, et al.
Pageof 20